Benzinga | Nov 3, 2021 10:04AM EDT

Morgan Stanley Maintains Overweight on Catalent, Raises Price Target to $160

Morgan Stanley maintains Catalent (NYSE:CTLT) with a Overweight and raises the price target from $147 to $160.